Literature DB >> 1712681

Inhibition of lymphocyte proliferation by a monoclonal antibody (RFT2) against CD7.

Y Costantinides1, G Kingsley, C Pitzalis, G S Panayi.   

Abstract

The effect of the monoclonal antibody RFT2, directed against CD7, on T cell proliferation in unseparated peripheral blood mononuclear cell populations induced by various stimulants was investigated. The addition of RFT2 to cell cultures inhibited the T cell proliferation induced by tuberculin PPD and OKT3 but not by phytohaemagglutinin, concanavalin A or phorbol myristic acid; RFT2 had to be present during the first 24 h of culture in order to elicit inhibition; inhibition of proliferation was not due to down regulation of interleukin-2 receptor on the surface of T cells; and suppressive effects could be transferred by mononuclear cells pre-treated with RFT2. These results are of particular relevance in view of the known in vivo suppressive effect of RFT2 in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712681      PMCID: PMC1535725          DOI: 10.1111/j.1365-2249.1991.tb05698.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Decreased expression of CD7 occurs in rheumatoid arthritis.

Authors:  A I Lazarovits; J Karsh
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

2.  The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion.

Authors:  C Pitzalis; G Kingsley; D Haskard; G Panayi
Journal:  Eur J Immunol       Date:  1988-09       Impact factor: 5.532

3.  A monoclonal antibody, 7G5 (CD7), induces modulation of Tp40 and inhibits proliferation in the allogeneic and autologous mixed lymphocyte reactions.

Authors:  A I Lazarovits; J Karsh
Journal:  Transplant Proc       Date:  1988-12       Impact factor: 1.066

4.  Response to monoclonal CD7 antibody in rheumatoid arthritis.

Authors:  B Kirkham; I Chikanza; C Pitzalis; G H Kingsley; R Grahame; T Gibson; G S Panayi
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

5.  Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.

Authors:  Y Morishima; M Kobayashi; S Y Yang; N H Collins; M K Hoffmann; B Dupont
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

6.  Activated T lymphocytes of the synovial membrane in rheumatoid arthritis and other arthropathies.

Authors:  L W Poulter; O Duke; G S Panayi; S Hobbs; M J Raftery; G Janossy
Journal:  Scand J Immunol       Date:  1985-12       Impact factor: 3.487

7.  Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure.

Authors:  O Lider; N Karin; M Shinitzky; I R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies.

Authors:  A C Carrera; M Rincón; F Sánchez-Madrid; M López-Botet; M O de Landaźuri
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

9.  Phosphorylation of T cell membrane proteins by activators of protein kinase C.

Authors:  T A Chatila; R S Geha
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

  9 in total
  2 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  K12/SECTM1, an interferon-γ regulated molecule, synergizes with CD28 to costimulate human T cell proliferation.

Authors:  Tao Wang; Catherine Huang; Alfonso Lopez-Coral; Kimberly A Slentz-Kesler; Min Xiao; E John Wherry; Russel E Kaufman
Journal:  J Leukoc Biol       Date:  2011-12-19       Impact factor: 4.962

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.